Symbol="RNA"
AssetType="Common Stock"
Name="Avidity BiosciencesÂ Inc"
Description="Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California."
CIK="1599901"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10975 N. TORREY PINES RD.,, #150, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="596298000"
EBITDA="-206712992"
PERatio="None"
PEGRatio="0"
BookValue="7.55"
DividendPerShare="0"
DividendYield="0"
EPS="-3.17"
RevenuePerShareTTM="0.155"
ProfitMargin="0"
OperatingMarginTTM="-21.26"
ReturnOnAssetsTTM="-0.253"
ReturnOnEquityTTM="-0.414"
RevenueTTM="9800000"
GrossProfitTTM="-141180000"
DilutedEPSTTM="-3.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.063"
AnalystTargetPrice="36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="119.0"
PriceToBookRatio="1.576"
EVToRevenue="24.07"
EVToEBITDA="-1.227"
Beta="-0.0912"
num_52WeekHigh="25.74"
num_52WeekLow="8.2"
num_50DayMovingAverage="10.58"
num_200DayMovingAverage="15.54"
SharesOutstanding="70819000"
DividendDate="None"
ExDividendDate="None"
symbol="RNA"
open="8.15"
high="8.42"
low="8.07"
price="8.24"
volume="493843.00"
latest_trading_day="2023-08-18"
previous_close="8.25"
change="-0.01"
change_percent="-0.1212%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="1182330"
Change_recent_avg="-0.08"
Delta_recent_avg="0.67"
Variance_recent_avg="0.34"
Change_ratio_recent_avg="-0.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="514"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="1011"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_positive_thumbnail_id_2="691"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
